| Primary |
| Adrenal Insufficiency |
14.3% |
| Cardiac Failure Congestive |
14.3% |
| Hormone Replacement Therapy |
14.3% |
| Hypertension |
14.3% |
| Orthostatic Hypotension |
14.3% |
| Pain |
14.3% |
| Syncope Vasovagal |
14.3% |
|
| Hypokalaemia |
33.3% |
| Oedema Peripheral |
33.3% |
| Condition Aggravated |
16.7% |
| Hallucination |
16.7% |
|
| Secondary |
| Product Used For Unknown Indication |
24.7% |
| Adrenogenital Syndrome |
13.7% |
| Pain |
8.4% |
| Drug Use For Unknown Indication |
4.7% |
| Addison's Disease |
4.2% |
| Adrenal Insufficiency |
4.2% |
| Convulsion |
4.2% |
| Analgesic Therapy |
3.7% |
| Prophylaxis Against Renal Transplant Rejection |
3.7% |
| Constipation |
3.2% |
| Deep Vein Thrombosis |
3.2% |
| Fatigue |
3.2% |
| Multiple Myeloma |
3.2% |
| Pulmonary Embolism |
3.2% |
| Orthostatic Hypotension |
2.6% |
| Chemotherapy |
2.1% |
| Hyponatraemia |
2.1% |
| Pain Prophylaxis |
2.1% |
| Routine Health Maintenance |
2.1% |
| Back Pain |
1.6% |
|
| Drug Interaction |
25.0% |
| Tremor |
9.1% |
| Pulmonary Embolism |
6.8% |
| Tumour Haemorrhage |
6.8% |
| Death |
4.5% |
| Platelet Count Decreased |
4.5% |
| Renal Salt-wasting Syndrome |
4.5% |
| Respiratory Distress |
4.5% |
| Suicide Attempt |
4.5% |
| Toxicity To Various Agents |
4.5% |
| Weight Decreased |
4.5% |
| Adrenocortical Insufficiency Acute |
2.3% |
| Blood Creatinine Increased |
2.3% |
| Cardiac Arrest |
2.3% |
| Cardio-respiratory Arrest |
2.3% |
| Epilepsy |
2.3% |
| Hypercalcaemia |
2.3% |
| Hypertensive Encephalopathy |
2.3% |
| Ischaemic Stroke |
2.3% |
| Klebsiella Bacteraemia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.6% |
| Drug Use For Unknown Indication |
30.3% |
| Diabetes Mellitus |
3.0% |
| Pain |
3.0% |
| Hypertension |
2.4% |
| Anxiety |
2.1% |
| Adrenal Insufficiency |
1.9% |
| Migraine |
1.9% |
| Parkinson's Disease |
1.9% |
| Prophylaxis |
1.8% |
| Addison's Disease |
1.7% |
| Depression |
1.6% |
| Diffuse Large B-cell Lymphoma |
1.5% |
| Adrenogenital Syndrome |
1.5% |
| Nuclear Magnetic Resonance Imaging |
1.5% |
| Osteoporosis |
1.4% |
| Metastases To Bone |
1.3% |
| Schizophrenia |
1.3% |
| Atrial Fibrillation |
1.2% |
| Rheumatoid Arthritis |
1.2% |
|
| Weight Decreased |
14.1% |
| Vomiting |
13.6% |
| Pyrexia |
8.9% |
| Somnolence |
6.8% |
| White Blood Cell Count Decreased |
6.3% |
| Rhabdomyolysis |
5.2% |
| Syncope |
5.2% |
| Death |
4.7% |
| Renal Failure |
3.7% |
| Dizziness |
3.1% |
| Hypoaldosteronism |
3.1% |
| Loss Of Consciousness |
3.1% |
| Respiratory Failure |
3.1% |
| Urinary Tract Infection |
3.1% |
| Gastrointestinal Haemorrhage |
2.6% |
| Pain |
2.6% |
| Renal Failure Acute |
2.6% |
| Septic Shock |
2.6% |
| Thrombocytopenia |
2.6% |
| Toxicity To Various Agents |
2.6% |
|
| Interacting |
| Adrenogenital Syndrome |
50.0% |
| 21-Hydroxylase Deficiency |
16.7% |
| Convulsion |
16.7% |
| Epilepsy |
16.7% |
|
| Drug Interaction |
75.0% |
| Renin Increased |
25.0% |
|
